Application of costunolide and/or dehydrocostus lactone in preparation of medicine for treating melanoma

A technology for dehydroxylactone and xylolide, which is applied in the field of biomedicine and can solve the problems of obvious adverse reactions, large trauma and the like

Inactive Publication Date: 2020-08-11
SHENZHEN SUNNY BIO TECH CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main methods of conventional treatment for melanoma are surgery, radiotherapy and chemotherapy, but there are technical problems of large trauma and obvious adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of costunolide and/or dehydrocostus lactone in preparation of medicine for treating melanoma
  • Application of costunolide and/or dehydrocostus lactone in preparation of medicine for treating melanoma
  • Application of costunolide and/or dehydrocostus lactone in preparation of medicine for treating melanoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1 MTT method is used to determine the effect on the proliferation of melanoma cell B16 cells

[0050] Take mouse B16 melanoma cells in the logarithmic growth phase, count the cells under a microscope, and adjust the cell concentration to 1×10 5 cells / mL, inoculated into 96-well plate, 100 μL cell liquid per well, that is, 1×10 4 Each well, after the cells grow on the wall overnight, add 100 μL of fresh medium containing arylactone or dehydrocresinolide, and set the drug concentration to 3.125 μM, 6.25 μM, 12.5 μM, 25 μM, 50 μM, and set There is a blank control group without drug addition, and 6 replicate wells are set up in each group, and cultured for 24, 48 and 72 hours respectively, and 20 μL of MTT solution is added to each well, and the cell incubator is further cultivated for 4 hours, the old medium is discarded, and 200 μL DMSO is added to each well, The absorbance value was measured with a microplate reader A570nm.

[0051] Cell proliferation inhibitio...

Embodiment 2D

[0056] Example 2 Observation of Apoptosis by Fluorescence Microscopy after DAPI Staining Cell Nuclei

[0057] Take 3mL1×10 5 cells / mL of B16 cells, inoculated into a 60mm petri dish with glass slides, after growing on the wall overnight, discarded the old medium, and added 3 mL of coycinolide or dehydrocoynelide at a concentration of 25 μM respectively. Fresh culture medium, set blank control group, place in cell culture incubator for 48 hours, wash twice with PBS, add pre-cooled 75% ethanol, fix overnight in 4°C refrigerator, discard fixative, add PBS to wash Three times, add DAPI staining solution, protect from light at 37°C for 30 minutes, wash with PBS, observe cell morphology under a fluorescent inverted microscope, and take pictures for analysis.

[0058] The result is as follows:

[0059] After B16 cells were treated with xylolide, the number of cells observed under the microscope was significantly reduced, and there were shrinkage and digestion phenomena. After DAPI...

Embodiment 3

[0062] Example 3 FCM detection and analysis of cell apoptosis by flow cytometry

[0063] Take 3mL1×10 5 cells / mL of B16 cells were inoculated into a 60mm culture dish, and after growing overnight, the old medium was discarded, and fresh medium containing different concentrations of drugs was added, and the group without adding drugs was set as the control group. Place in the cell incubator and continue to culture for 48 hours, digest the cells with EDTA-free trypsin, centrifuge at 1000 rpm for 5 minutes, discard the supernatant, wash twice with PBS, resuspend the cells in PBS, and take 1×104 resuspended cells, After centrifugation, add 195 μL AnnexinV-FITC conjugate solution and gently resuspend the cells. Add 5 μL AnnexinV-FITC staining solution, mix gently, add 10 μL PI, mix gently. Incubate at room temperature in the dark for 20 min, then place on ice, detect by flow cytometry, and analyze the apoptosis rate.

[0064] The result is as follows:

[0065] Flow cytometry de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides application of costunolide and / or dehydrocostus lactone in preparation of a medicine for preventing and / or treating melanoma, and belongs to the technical field of biological medicines. According to the invention, the costunolide and / or the dehydrocostus lactone can inhibit the proliferation of melanoma cells B16 and induce apoptosis, and has an anti-melanoma effect.

Description

technical field [0001] The invention relates to the technical field of biomedicine, and in particular to the application of corylidene and / or dehydrocorylide in the preparation of medicines for treating melanoma. Background technique [0002] Melanoma, also known as malignant melanoma (Malignant Melanoma, MM), is known as the "King of Skin Cancer". It is the most dangerous type of skin cancer and has a strong ability to proliferate. The detection rate of melanoma in China is increasing, and new cases continue to increase every year. At present, the main methods of routine treatment of melanoma are surgery, radiotherapy and chemotherapy, but there are technical problems of large trauma and obvious adverse reactions. Contents of the invention [0003] The object of the present invention is to provide the application of coynelide and / or dehydrocoylide in the preparation of medicines for the treatment of melanoma, coylide and / or dehydrocoylide inhibit melanoma cells Prolifer...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/365A61K31/704A61K31/715A61K9/16A61K9/20A61K9/00A61K9/48A61K9/06A61K9/14A61P35/00
CPCA61K9/0014A61K9/0095A61K9/06A61K9/14A61K9/1652A61K9/2059A61K9/48A61K31/365A61K31/704A61K31/715A61K47/06A61P35/00A61K2300/00
Inventor 刘蕊王丹丹张景照唐旭东
Owner SHENZHEN SUNNY BIO TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products